TuisILMN • NASDAQ
add
Illumina Inc
Vorige sluiting
$139,68
Dagwisseling
$133,98 - $137,18
Jaarwisseling
$97,27 - $156,66
Markkapitalisasie
21,68 mjd USD
Gemiddelde volume
1,93 m
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NASDAQ
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 1,08 mjd | -3,49% |
Bedryfskoste | 502,00 m | -17,43% |
Netto inkomste | 705,00 m | 193,50% |
Netto winsgrens | 65,28 | 196,88% |
Wins per aandeel | 1,14 | 245,45% |
EBITDA | 329,00 m | 41,81% |
Effektiewe belastingkoers | 2,08% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 939,00 m | 0,64% |
Totale bates | 6,01 mjd | -40,58% |
Totale aanspreeklikheid | 3,89 mjd | -7,93% |
Totale ekwiteit | 2,12 mjd | — |
Uitstaande aandele | 158,60 m | — |
Prys om te bespreek | 10,39 | — |
Opbrengs op bates | 10,71% | — |
Opbrengs op kapitaal | 14,14% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | 705,00 m | 193,50% |
Kontant van bedrywe | 316,00 m | 127,34% |
Kontant van beleggings | -41,00 m | 22,64% |
Kontant van finansiering | -332,00 m | 53,04% |
Netto kontantverandering | -51,00 m | 91,85% |
Beskikbare kontantvloei | -198,62 m | -184,66% |
Meer oor
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries.
Illumina's customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies. Wikipedia
Gestig
1998
Hoofkwartier
Webwerf
Werknemers
10 615
